Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2022-05-23 00:00:00 ET · period of report 2022-05-23 · accession 0001209191-22-031402 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-23 | 2022-05-23 | DFTX | Greenway Schond L. | CFO | A - Grant | $0.00 | +1.27M | 1.27M | New | $0 |
| D | 2022-05-23 | 2022-05-23 | DFTX | Greenway Schond L. | CFO | A - Grant | $0.00 | +1.65M | 1.65M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2022-05-23 | A | A | 1,270,000 | $0.00 | 1,270,000 | D | — | — | (F1) These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on May 23, 2023 with 1/12th of the remaining shares vesting each quarter thereafter over 12 quarters, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-23 | A | A | 1,650,000 | $0.00 | 1,650,000 | D | $0.71 · — to 2027-05-22 | 1,650,000 Subordinate Voting Shares | (F2) The option grant has an exercise price of $0.91 Canadian Dollars. This represents the exercise price in United States Dollars. (F3) The shares subject to the option vest and become exercisable, with 25% vesting on May 23, 2023, and 1/36th of the remaining shares vesting monthly thereafter over 36 months, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date. |